retatrutide glp1 vs Semaglutide and Tirzepatide: GLP-3 Facts explained The power of three: Retatrutide's

Here are a few simple tips: Start low, go slow: Start with a lower dose and only increase if needed

Microdosing is about splitting, not adding more medication

Phase 3 results published in December 2025 from the TRIUMPH-4 trial a double-blind, placebo-controlled study in 445 adults with obesity or overweight and knee osteoarthritis showed the 12mg dose producing an average of 28.7% body weight reduction at 68 weeks

Kambic, T., Lavie, C

is supported by a Project Grant from the Canadian Institutes for Health Research (CIHR), an End Diabetes Award from Diabetes Canada and a Tier 2 Canada Research Chair (Pharmacotherapy of Energy Metabolism in Obesity)